SCHEMBL9603905

SCHEMBL9603905

Cc1cccc2c1sc1c(-c3ccc(-c4nc5ccccc5o4)cc3)cccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.48
KDM4E B2RXH2 6/20 0.48
ALDH1A1 P00352 6/20 0.48
HPGD P15428 6/20 0.48
SMN1; SMN2 Q16637 6/20 0.48
HSD17B10 Q99714 3/20 0.48
TP53 P04637 3/20 0.48
RAB9A P51151 8/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ATM Q13315 1/20 0.48
MAPT P10636 6/20 0.47
USP2 O75604 2/20 0.47
HCRTR1 O43613 2/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
CASP3 P42574 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9603904 0.91 KDM4E (0.48) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL9603915 0.90 NPC1 (0.52) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL8512669 0.85 NPC1 (0.50) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL9603887 0.84 NPC1 (0.49) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21891137 0.83 NPC1 (0.49) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL9603918 0.82 TP53 (0.51) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21742591 0.81 NPC1 (0.61) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL9603901 0.81 NPC1 (0.48) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21891140 0.81 ALDH1A1 (0.46) NPC1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL9603889 0.81 NPC1 (0.48) NPC1KDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device XDH, AOX1, CYP4X1 NPC1 4611/4885KDM4E 2142/4885ALDH1A1 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.